Related Experiment Video
Updated: Jul 5, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
SSF-DDI: a deep learning method utilizing drug sequence and substructure features for drug-drug interaction
Jing Zhu1, Chao Che2, Hao Jiang1
1Key Laboratory of Advanced Design and Intelligent Computing, Ministry of Education, Dalian University, Dalian, 116000, China.
This study introduces a new model for predicting drug-drug interactions (DDI) by integrating drug sequence and substructure features. The SSF-DDI model significantly improves DDI prediction accuracy, especially for unknown drugs.
Area of Science:
- Pharmacology
- Computational Chemistry
- Bioinformatics
Background:
- Drug-drug interactions (DDI) are common in combination therapy.
- Existing artificial intelligence methods for DDI prediction often neglect crucial sequence and substructure information of drug molecules.
Purpose of the Study:
- To develop a novel model for DDI prediction that incorporates both sequence and substructure features.
- To enhance the accuracy and comprehensiveness of DDI prediction by leveraging detailed molecular information.
Main Methods:
- Proposed the Sequence and Substructure Features for DDI (SSF-DDI) prediction model.
- Integrated drug sequence information with structural features derived from drug molecule graphs.
Main Results:
- The SSF-DDI model demonstrated superior performance compared to state-of-the-art DDI prediction models across various datasets.
- Achieved a 5.67% improvement in accuracy for predicting DDI involving unknown drugs.
Conclusions:
- The SSF-DDI model offers a more comprehensive and accurate approach to DDI prediction.
- The integration of sequence and substructure features is effective in improving DDI prediction, particularly for novel drug combinations.
More Related Videos
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Related Concept Videos
Drug Discovery: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Protein-protein Interfaces
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...